CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
Graves' disease (GD) is an organ-specific autoimmune disorder of multifactorial etiology with a polygenic mode of inheritance. A recent report has demonstrated that there is a linkage and an association between the genetic markers of the CTLA-4 gene on chromosome 2q33 and GD. In order to confirm this association in a Tunisian population, three polymorphisms of the CTLA-4 gene were analyzed: the first is at the -318 position from the ATG start codon consisting of a C/T change; the second is in position 49 of exon 1, which lies in the A/G transition; and the third is in the 3' untranslated region with variant lengths of the dinucleotide (AT)n repeat. The genomic DNA from 144 patients with GD and 205 healthy individuals was genotyped after specific polymerase chain reaction amplification. Comparative analysis using a chi(2) test showed a weak yet significant difference in allele frequencies of the A/G dimorphic marker between patients and controls (P < 0.05), and a significant increase of A/A homozygous individuals among patients (21.53 vs 12.7%, P = 0.02, odds ratio (OR) = 1.89) was found. Analyses of CTLA-4 A/G polymorphism with respect to sex showed a significant difference in A/A genotypes between female patients and controls (OR = 2.14; 95%, 1.13 < OR < 4.04, P < 0.05). The distribution of CTLA-4 (AT)n allele frequencies differed between patients and controls (chi(2) = 38.18, 20 degrees of freedom, P = 0.0084) and the highest OR was found with the CTLA-4 (AT)-224-bp allele (OR = 6.43, 1.7 < OR < 28.64; P = 0.001). In conclusion, these results show that the CTLA-4 gene, or one closely associated with it, confers susceptibility to GD in a Tunisian population.
Hadj Kacem
H
H
Faculté de Médecine, Laboratoire de Génétique Moléculaire Humaine, Sfax, Tunisia.
Bellassoued
M
M
Bougacha-Elleuch
N
N
Abid
M
M
Ayadi
H
H
D000069594:Abatacept; D000483:Alleles; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000235:genetics*; D060908:CTLA-4 Antigen; D002889:Chromosomes, Human, Pair 2; D005260:Female; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006111:Graves Disease / Q000235:genetics*; D006801:Humans; D018796:Immunoconjugates; D008297:Male; D011110:Polymorphism, Genetic; D014416:Tunisia
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D005819:Genetic Markers; D018796:Immunoconjugates; D000069594:Abatacept